FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cortisone Acetate Tablets
Status: Currently in Shortage
»Date first posted: 03/26/2021
»Therapeutic Categories: Endocrinology/Metabolism; Rheumatology

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 07/06/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg, bottles of 100 (NDC 0143-9700-01) Currently Unavailable. Estimated shortage duration: TBD Shortage of an active ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English